Bodyl A Brand

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersWomen's studies (incl. girls' studies)Psychosocial aspects of childbirth and perinatal mental healthClinical pharmacology and therapeuticsCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 12, 2024
Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition.

Bodyl A Brand, Janna N de Boer, Elske J M Willemse

|Oct 21, 2023
Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders.

Bodyl A Brand, Elske J M Willemse, Iris M H Hamers

|Apr 28, 2023
The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial.

Bodyl A Brand, Janna N de Boer, Machteld C Marcelis

|Nov 12, 2021
Antipsychotic medication for women with schizophrenia spectrum disorders.

Bodyl A Brand, Yudith R A Haveman, Franciska de Beer

|Oct 19, 2020
Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis.

Marieke J Begemann, Bodyl A Brand, Branislava Ćurčić-Blake

Pageof 1

Frequent Collaborators

2 joint publications

Janna N de Boer

1 joint publications

Franciska de Beer

1 joint publications

Paola Dazzan

1 joint publications

Iris E C Sommer